In 1998, I was diagnosed with metastatic melanoma and given months to live. I consulted more than a dozen leading oncologists and got conflicting recommendations. No one could tell me: ‘Which treatment is best for me?’

A clinical trial saved my life—despite itself being unsuccessful—only raising more questions. Why did this therapy work for me but not for others? Could my experience help similar patients? It was life-saving knowledge I wanted to share with all cancer patients.

Welcome to Cancer Commons.

Marty Tenenbaum, PhD Founder of Cancer Commons

Help for Advanced Cancer Patients: Learn More or

Get Started Now

Our Services

We provide patients and their care teams with the actionable information and data they need to make informed decisions. We help identify and access individualized regimen of therapies that specifically target the molecular drivers of their disease and refer patients to a myriad of precision oncology services to help them navigate the cancer maze and minimize trial and error.

Get Help

Always Learning

What makes Cancer Commons unique is our continuous learning health system.

As we help patients identify and access novel tests, treatments, and trials, we learn continuously from every patient's experience—and share that knowledge with the world.

Learn More

Support Us

We've been helping cancer patients for more than a decade—and our services are free, supported by generous donations/philanthropy.

Please help us continue our work serving patients and changing the field of oncology with tax-deductible donation in any amount, and learn about other ways to support our mission.

Support Us

Since our founding in 2011, we have delivered personalized, evidence-based guidance at no charge to more than 10,000 patients and caregivers, supported entirely by philanthropy.

Get Help

  • The tumor board report summarized a lot of information into a very easy to read and understandable format. It provided contact information for additional treatment options which we will be pursuing. Lola Rahib was very efficient in obtaining all my medical records and responded quickly to our initial inquiry.

    Tony
    Pancreatic cancer patient

  • The team was a great complement to my local oncology team! The findings of the analysis and tumor board recommendations helped confirm that our “First line standard of care” was corroborated and also offered a potential map of 2nd and 3rd line care. Further, clinical trials pertinent to my specific genomic cancer were identified with the closest providers currently offering trial enrollment.

    Mary Lou
    Metastatic colorectal cancer patient

  • The personalized “second opinion” did wonders to reassure that I was on the right path to manage my disease. The process was transparent and remarkably easy. My personal thanks to Lola for the constant feedback and communication.

    Dave
    Patient with metastatic neuroendocrine tumor of the pancreas

  • Cancer Commons is the absolute best for helping when diagnosed with cancer. They help you understand your cancer and all the treatment options, including clinical trials. I have relied on them for many friends, and don’t know what I would do without them.

    Reggie
    Friend of a metastatic ovarian cancer patient, and many others

  • Absolutely wonderful!! Matt is a wealth of knowledge and so prompt at getting back to emails and reporting findings or results. It really is incredible to have this resource free of charge as a second opinion, and gives me comfort knowing what we are doing is the best we can do for now, leaving no stone unturned. We appreciate Cancer Commons so very much!!

    Jessica
    Daughter of a grade IV glioblastoma patient

Cancer Commons is staffed by accomplished researchers with PhDs in the molecular biology and pharmacology of cancer and in Artificial Intelligence. They have joined the Commons to apply their knowledge and expertise to help patients research their options in real time using the latest tools of precision oncology.

Meet the Team
More News...